| Bioactivity | (E)-Aztreonam (SQ-28429) is a monocyclic beta-lactam antibiotic. (E)-Aztreonam has the potential for the research of infections caused by gram-negative pathogens[1][2][3]. |
| In Vivo | (E)-Aztreonam (28 mg/kg; i.p.; daily for 14 days) 可诱导腹膜细胞活化水平升高，增加小鼠腹膜巨噬细胞产生 IL-1 的能力[3]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
| CAS | 99341-02-3 |
| Formula | C13H17N5O8S2 |
| Molar Mass | 435.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Neu HC. Aztreonam activity, pharmacology, and clinical uses. Am J Med. 1990 Mar 23;88(3C):2S-6S; discussion 38S-42S. [2]. Childs, S. J., et al. Aztreonam. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986, 6(4), 138-149. [3]. Ortega E, et al. Effects of aztreonam on natural immunity in mice. Int J Antimicrob Agents. 1999 Sep;13(1):41-6. |
(E)-Aztreonam
CAS: 99341-02-3 F: C13H17N5O8S2 W: 435.43
(E)-Aztreonam (SQ-28429) is a monocyclic beta-lactam antibiotic. (E)-Aztreonam has the potential for the research of inf
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.